ClinicalTrials.gg
RecruitingNCT02803242COPD PPRNUpdated Mar 10, 2022

COPD Patient-Powered Research Network

An observational study in Chronic Obstructive Pulmonary Disorder, Chronic Obstructive Lung Disease and Emphysema, sponsored by COPD Foundation. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-10.

Primary conditionBronchitis, ChronicRegistry: Pulmonary Disease, Chronic ObstructiveReclassifiedWhy we changed it
Registry
Pulmonary Disease, Chronic Obstructive — the first condition term the registry derived for this study.
ClinicalTrials.gg
Bronchitis, Chronic
Why
  1. The study's listed conditions name Bronchitis, Chronic, a narrower term within Pulmonary Disease, Chronic Obstructive.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by COPD Foundation · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
75,000
Ages
18 Years and older
Sex
All
01

Study summary

The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform to allow volunteers to enroll electronically, complete surveys, be contacted about studies they qualify for and become connected to COPD resources. The goal of the registry is to speed research to find better treatments for COPD and ultimately a cure.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disorder
  • Chronic Obstructive Lung Disease
  • Emphysema
  • Chronic Bronchitis

Keywords

  • copd
  • emphysema
  • bronchitis
  • bronchiectasis
03

In context

Bronchitis, Chronic Reclassified

209 studies on the registry are indexed under Bronchitis, Chronic; 14 are open to participants now.

This study's planned enrollment of 75,000 is above the median of 988 across 46 observational studies indexed under Bronchitis, Chronic.

Browse Bronchitis, Chronic studies →

Lead sponsor

COPD Foundation is the lead sponsor of 6 studies on the registry; 3 are open to participants now.

Compared within Bronchitis, Chronic, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Pulmonary Disease, Chronic Obstructive. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

English speaking individuals who are over the age of 18 and have a diagnosis of COPD or fall into one of the following categories that put's them at risk - current or former smoker, environmental/occupational exposure, family history of respiratory disease or symptomatic of respiratory disease.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years or older that says yes to one of the following:
  • diagnosis
  • Current or former smoker
  • Family history of respiratory disease
  • Symptomatic of respiratory disease

Exclusion criteria

Exclusion Criteria:

  • Non-English speaking
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
75,000 participants (estimated)
Target follow-up
15 Years
Patient registry
Yes

Interventions

  • OtherPatient Reported Outcomes

    Also known as: Patient reported outcomes will be collected using self-report questionnaires to asses lung health status

06

What researchers measure

Primary outcomes

  1. Patient Reported Outcome Measurement Information System-29 (PROMIS-29)

    Time frame: 15 years

  2. COPD Assessment Test (CAT)

    Time frame: 15 years

  3. Modified Medical Research Council (MMRC) Dyspnea Scale

    Time frame: 15 years

  4. Charlson Comorbidity Index (CCI)

    Time frame: 15 years

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02803242
Lead sponsor
COPD Foundation
Collaborators
Kaiser Foundation Hospitals, Center for Health Research
Responsible party
Sponsor
First posted
Jun 16, 2016
Start date
Aug 2014
Primary completion
Jan 2025 (estimated)
Completion
Jan 2030 (estimated)
Last update
Mar 10, 2022

Study contacts

Gretchen M McCreary, MA
Contact
gmccreary@copdfoundation.org
866-731-2673 ext. 396
Elisha Malanga
Contact
emalanga@copdfoundation.org
866-731-2673 ext. 309

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion